0001209191-22-020753.txt : 20220323
0001209191-22-020753.hdr.sgml : 20220323
20220323160018
ACCESSION NUMBER: 0001209191-22-020753
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20220311
FILED AS OF DATE: 20220323
DATE AS OF CHANGE: 20220323
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tray Thomas
CENTRAL INDEX KEY: 0001912317
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12400
FILM NUMBER: 22763159
MAIL ADDRESS:
STREET 1: C/O INCYTE CORPORATION
STREET 2: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INCYTE CORP
CENTRAL INDEX KEY: 0000879169
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 943136539
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
BUSINESS PHONE: 3024986700
MAIL ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE CORP
DATE OF NAME CHANGE: 20030318
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE GENOMICS INC
DATE OF NAME CHANGE: 20000710
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930902
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2022-03-11
0
0000879169
INCYTE CORP
INCY
0001912317
Tray Thomas
1801 AUGUSTINE CUT-OFF
WILMINGTON
DE
19803
0
1
0
0
Principal Accounting Officer
Common Stock
3238
D
Common Stock
1399
I
By Spouse
Common Stock
554
D
Common Stock
1886
D
Common Stock
2870
D
Common Stock
2322
D
Common Stock
3649
D
Incentive Stock Option (right to buy)
95.76
2026-01-06
Common Stock
1044
D
Non-Qualified Stock Option (right to buy)
95.76
2026-01-06
Common Stock
1730
D
Incentive Stock Option (right to buy)
95.76
2023-01-06
Common Stock
1005
D
Non-Qualified Stock Option (right to buy)
95.76
2023-01-06
Common Stock
2436
D
Non-Qualified Stock Option (right to buy)
83.83
2026-07-14
Common Stock
2639
D
Incentive Stock Option (right to buy)
113.64
2027-01-16
Common Stock
879
D
Non-Qualified Stock Option (right to buy)
113.64
2027-01-16
Common Stock
2642
D
Non-Qualified Stock Option (right to buy)
113.64
2027-01-16
Common Stock
2639
D
Non-Qualified Stock Option (right to buy)
128.34
2027-07-04
Common Stock
1677
D
Incentive Stock Option (right to buy)
94.63
2028-01-22
Common Stock
1
D
Non-Qualified Stock Option (right to buy)
94.63
2028-01-22
Common Stock
1676
D
Incentive Stock Option (right to buy)
95.34
2028-01-23
Common Stock
1048
D
Non-Qualified Stock Option (right to buy)
95.34
2028-01-23
Common Stock
5443
D
Incentive Stock Option (right to buy)
68.62
2028-07-01
Common Stock
1
D
Non-Qualified Stock Option (right to buy)
68.62
2028-07-01
Common Stock
5172
D
Incentive Stock Option (right to buy)
72.27
2029-01-03
Common Stock
1383
D
Non-Qualified Stock Option (right to buy)
72.27
2029-01-03
Common Stock
3349
D
Non-Qualified Stock Option (right to buy)
72.27
2029-01-03
Common Stock
5173
D
Non-Qualified Stock Option (right to buy)
85.01
2029-07-01
Common Stock
2289
D
Non-Qualified Stock Option (right to buy)
80.50
2030-01-16
Common Stock
2290
D
Incentive Stock Option (right to buy)
106.47
2030-07-01
Common Stock
324
D
Non-Qualified Stock Option (right to buy)
106.47
2030-07-01
Common Stock
1896
D
Incentive Stock Option (right to buy)
90.56
2031-01-14
Common Stock
324
D
Non-Qualified Stock Option (right to buy)
90.56
2031-01-14
Common Stock
1896
D
Incentive Stock Option (right to buy)
83.58
2031-07-01
Common Stock
815
D
Non-Qualified Stock Option (right to buy)
83.58
2031-07-01
Common Stock
1808
D
Incentive Stock Option (right to buy)
74.78
2032-01-18
Common Stock
383
D
Non-Qualified Stock Option (right to buy)
74.78
2032-01-18
Common Stock
2240
D
Represents restricted stock units ("RSUs") granted on July 2, 2018 that will vest fully on July 2, 2022.
Represents restricted stock units ("RSUs") granted on July 2, 2019 that will vest 943 on July 2, 2022 and the remaining on July 2, 2023.
Represents restricted stock units ("RSUs") granted on January 17, 2020 that will vest fully on January 17, 2024.
Represents restricted stock units ("RSUs") granted on July 2, 2020 that will vest 774 on July 2, 2022, July 2, 2023 and July 2, 2024.
Represents restricted stock units ("RSUs") granted on July 2, 2021 that will vest 912 on July 2, 2022, July 2, 2023, July 2, 2024 and the remaining will vest on July 2, 2025.
As of March 11,2022, the award is fully vested and exercisable.
Option granted on July 2, 2018 and becomes exercisable on July 2,2022.
Options granted on July 2, 2018 and will vest monthly through July 2,2022.
Options granted on January 4, 2019 and become exercisable in full on January 4, 2023.
Options granted on January 4, 2019 and vest monthly through July 2,2022.
Options granted on July 2, 2019 and vest monthly through July 2,2023.
Options granted on January 17, 2020 and vest monthly through July 2,2023.
Options granted on July 2, 2020 and will vest monthly starting January 2, 2024 through July 2, 2024.
Options granted on July 2, 2020 and will vest monthly through December 2, 2023.
Options granted on January 15, 2021 and will vest monthly starting January 2, 2024 through July 2, 2024
Options granted on January 15, 2021 and will vest monthly through December 2, 2023.
Options granted on July 2, 2021 and will vest monthly starting January 2, 2024 through July 2, 2025.
Options granted on July 2, 2021 with 655 vesting on July 2, 2022 and the remainder vesting monthly through December 2, 2024.
Options granted on January 19, 2022 and will vest monthly starting January 2, 2025 through July 2, 2025.
Options granted on January 19, 2022 with 655 vesting on July 2, 2022 and the remainder vesting monthly through December 2, 2024.
/s/ Elizabeth Feeney
2022-03-23
EX-24
2
poa.txt
POA DOCUMENT
Power of Attorney
Know all by these presents that the undersigned hereby constitutes and appoints
each of Maria E. Pasquale, Christiana Stamoulis, and Elizabeth Feeney, signing
singly, the undersigned's true and lawful attorney-in-fact to:
(1) execute for and on behalf of the undersigned, in the undersigned's capacity
as an officer and/or director of Incyte Corporation (the "Company"), Forms 3, 4,
and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934
and the rules thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete and execute any such Form 3, 4, or 5,
complete and execute any amendment or amendments thereto, and timely file such
form with the United States Securities and Exchange Commission and any stock
exchange or similar authority; and
(3) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of March 11, 2022.
/s/ Thomas R. Tray, Jr.
Thomas R. Tray, Jr.